New Blood Test Detects 90% of Aggressive Prostate Cancer Cases

Hepatitis B is a serious liver infection caused by the hepatitis B virus. This virus spreads through contact with infected blood or other body fluids. Many people with hepatitis B may not show symptoms initially, making laboratory testing essential for diagnosis. The infection can be either acute, lasting a few weeks to months, or chronic, persisting for years and potentially leading to serious liver complications including cirrhosis and liver cancer.

Laboratory testing for hepatitis B involves several blood tests that detect different markers of the infection. The hepatitis B surface antigen test is typically the first screening test performed, as it indicates whether a person is currently infected with the virus. If this test is positive, additional tests are ordered to determine whether the infection is acute or chronic and how active the virus is in the body. These include tests for hepatitis B surface antibodies, hepatitis B core antibodies, and hepatitis B e-antigen and e-antibody. The hepatitis B DNA test measures the amount of virus in the blood and helps assess disease activity and treatment response.

Understanding test results is important for proper disease management. A positive surface antigen test indicates current infection, while a positive surface antibody test usually means the person has recovered from past infection or has been successfully vaccinated. The presence of core antibodies can indicate past or current infection. Healthcare providers use these test results together to determine the stage of infection, whether treatment is needed, and to monitor disease progression. Regular monitoring through laboratory tests is crucial for people with chronic hepatitis B to detect any changes in liver function and prevent serious complications.

Vaccination is highly effective at preventing hepatitis B infection. Laboratory testing can confirm whether a person has developed immunity after vaccination by checking for hepatitis B surface antibodies. People at higher risk of exposure, including healthcare workers, should be tested to ensure they have adequate protection. Early detection through laboratory testing allows for timely medical intervention and helps prevent transmission to others.